1. Home
  2. ZVRA vs MAGN Comparison

ZVRA vs MAGN Comparison

Compare ZVRA & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$8.92

Market Cap

502.7M

Sector

Health Care

ML Signal

HOLD

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$13.71

Market Cap

536.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVRA
MAGN
Founded
2006
1864
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
502.7M
536.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ZVRA
MAGN
Price
$8.92
$13.71
Analyst Decision
Strong Buy
Buy
Analyst Count
7
1
Target Price
$21.71
$18.00
AVG Volume (30 Days)
1.0M
495.6K
Earning Date
03-10-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$84,388,000.00
$3,204,000,000.00
Revenue This Year
$333.64
$5.74
Revenue Next Year
$43.58
$2.51
P/E Ratio
$16.79
N/A
Revenue Growth
244.60
46.50
52 Week Low
$6.19
$7.82
52 Week High
$13.16
$23.19

Technical Indicators

Market Signals
Indicator
ZVRA
MAGN
Relative Strength Index (RSI) 54.06 43.60
Support Level $8.75 $13.22
Resistance Level $9.60 $14.26
Average True Range (ATR) 0.46 0.54
MACD 0.04 -0.19
Stochastic Oscillator 58.55 20.32

Price Performance

Historical Comparison
ZVRA
MAGN

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

Share on Social Networks: